GlassScriptPhysician profile
D'Andra D Bingham
NPI 1336149905
$1,431.60
in general payments reported to CMS, 2019-2025
19 companies · $377 in 2025
The $377 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $74.76 · 2021: $90.10 · 2022: $242 · 2023: $281 · 2024: $260 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $917.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $321.44 | 2019-2025 | Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $205.60 | 2022-2025 | Veozah, Myrbetriq |
| Myovant Sciences INC. | $133.35 | 2021-2022 | |
| Pfizer INC. | $132.40 | 2020-2024 | |
| Sumitomo Pharma America, INC. | $127.52 | 2023-2025 | Myfembree |
| Biogen, INC. | $77.54 | 2024-2025 | Zurzuvae |
| Amgen INC. | $65.45 | 2019-2024 | Evenity, Prolia |
| Exact Sciences Corporation | $63.69 | 2025 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $51.50 | 2019-2020 | |
| Hologic Sales and Service, LLC | $43.19 | 2025 | Novasure, Myosure Tissue Removal Device |
| Amag Pharmaceuticals, INC. | $35.40 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $32.80 | 2022-2023 | Exparel |
| Organon LLC | $32.49 | 2022-2024 | |
| Novo Nordisk INC | $26.24 | 2020-2025 | Wegovy |
| Abbott Laboratories | $21.81 | 2025 | Cardiomems |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $16.20 | 2024 | |
| Therapeuticsmd, INC. | $15.82 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.66 | 2025 | Trintellix |
| Medtronic, INC. | $14.50 | 2025 | Ligasure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw D'Andra Bingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.